JP2012509902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509902A5 JP2012509902A5 JP2011537728A JP2011537728A JP2012509902A5 JP 2012509902 A5 JP2012509902 A5 JP 2012509902A5 JP 2011537728 A JP2011537728 A JP 2011537728A JP 2011537728 A JP2011537728 A JP 2011537728A JP 2012509902 A5 JP2012509902 A5 JP 2012509902A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- item
- cross
- linked
- life
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims description 112
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 112
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 112
- 238000000034 method Methods 0.000 claims description 51
- 238000001727 in vivo Methods 0.000 claims description 21
- 238000004132 cross linking Methods 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 210000000170 cell membrane Anatomy 0.000 claims description 4
- 230000001419 dependent effect Effects 0.000 claims description 4
- 230000003834 intracellular effect Effects 0.000 claims description 4
- 239000012466 permeate Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 102000051485 Bcl-2 family Human genes 0.000 description 2
- 108700038897 Bcl-2 family Proteins 0.000 description 2
- 239000007801 affinity label Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11750808P | 2008-11-24 | 2008-11-24 | |
| US61/117,508 | 2008-11-24 | ||
| PCT/US2009/065824 WO2010060112A1 (en) | 2008-11-24 | 2009-11-24 | Peptidomimetic macrocycles with improved properties |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015012176A Division JP6194325B2 (ja) | 2008-11-24 | 2015-01-26 | 改善された特性を有するペプチド模倣大環状分子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509902A JP2012509902A (ja) | 2012-04-26 |
| JP2012509902A5 true JP2012509902A5 (Direct) | 2012-06-07 |
Family
ID=42198556
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537728A Pending JP2012509902A (ja) | 2008-11-24 | 2009-11-24 | 改善された特性を有するペプチド模倣大環状分子 |
| JP2015012176A Expired - Fee Related JP6194325B2 (ja) | 2008-11-24 | 2015-01-26 | 改善された特性を有するペプチド模倣大環状分子 |
| JP2017118484A Withdrawn JP2017186363A (ja) | 2008-11-24 | 2017-06-16 | 改善された特性を有するペプチド模倣大環状分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015012176A Expired - Fee Related JP6194325B2 (ja) | 2008-11-24 | 2015-01-26 | 改善された特性を有するペプチド模倣大環状分子 |
| JP2017118484A Withdrawn JP2017186363A (ja) | 2008-11-24 | 2017-06-16 | 改善された特性を有するペプチド模倣大環状分子 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9458202B2 (Direct) |
| EP (1) | EP2352507A4 (Direct) |
| JP (3) | JP2012509902A (Direct) |
| CN (1) | CN102223891A (Direct) |
| AU (2) | AU2009316288B2 (Direct) |
| BR (1) | BRPI0920899A2 (Direct) |
| CA (1) | CA2743177A1 (Direct) |
| IL (1) | IL212748A (Direct) |
| WO (1) | WO2010060112A1 (Direct) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| CA2544223C (en) | 2003-11-05 | 2017-03-07 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| WO2005118620A2 (en) | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| US7981998B2 (en) * | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| EP3170835A1 (en) | 2006-12-14 | 2017-05-24 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| WO2008095063A1 (en) | 2007-01-31 | 2008-08-07 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2564863B1 (en) | 2007-02-23 | 2017-08-23 | Aileron Therapeutics, Inc. | Triazole linked macrocyclic peptides |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| US8871899B2 (en) * | 2007-12-31 | 2014-10-28 | New York University | Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| US20090275519A1 (en) | 2008-02-08 | 2009-11-05 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
| US20110144303A1 (en) * | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
| EP2356139A4 (en) * | 2008-07-23 | 2013-01-09 | Harvard College | LIGURE COMBINED POLYPEPTIDES |
| AU2009294875C1 (en) | 2008-09-22 | 2015-05-14 | Aileron Therapeutics, Inc. | Methods for preparing purified polypeptide compositions |
| WO2010034034A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2010060112A1 (en) | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
| BRPI1006139A2 (pt) | 2009-01-14 | 2017-05-30 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
| AU2010273220B2 (en) | 2009-07-13 | 2015-10-15 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| EP2480565A4 (en) | 2009-09-22 | 2014-01-01 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES |
| US20110223149A1 (en) * | 2009-10-14 | 2011-09-15 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN103282510A (zh) | 2010-08-13 | 2013-09-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| EP2651964B1 (en) | 2010-12-15 | 2018-02-28 | The Research Foundation of State University of New York | Cross-linked peptides and proteins, methods of making same, and uses thereof |
| WO2012174423A1 (en) | 2011-06-17 | 2012-12-20 | President And Fellows Of Harvard College | Stabilized polypeptides as regulators of rab gtpase function |
| CN103889437A (zh) * | 2011-08-31 | 2014-06-25 | 纽约大学 | 硫醚、醚和烷基胺连接的氢键替代物肽模拟物 |
| KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| WO2013102211A2 (en) | 2011-12-29 | 2013-07-04 | Walensky Loren D | Stabilized antiviral fusion helices |
| JP6450192B2 (ja) * | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス，インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
| WO2013123266A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| US9617309B2 (en) | 2012-09-26 | 2017-04-11 | President And Fellows Of Harvard College | Proline-locked stapled peptides and uses thereof |
| WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| KR102637496B1 (ko) | 2013-03-13 | 2024-02-19 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스테이플드 및 스티치드 폴리펩티드 및 그의 용도 |
| AU2014228777B2 (en) | 2013-03-15 | 2018-11-08 | Dana-Farber Cancer Institute, Inc. | BH4 stabilized peptides and uses thereof |
| WO2014144148A1 (en) | 2013-03-15 | 2014-09-18 | Dana-Farber Cancer Institute, Inc. | Stabilized sos1 peptides |
| WO2014151369A2 (en) | 2013-03-15 | 2014-09-25 | Dana-Farber Cancer Institute, Inc. | Stabilized ezh2 peptides |
| AU2014278005B2 (en) | 2013-06-14 | 2018-11-22 | President And Fellows Of Harvard College | Stabilized polypeptide insulin receptor modulators |
| KR102302634B1 (ko) | 2013-09-13 | 2021-09-14 | 더 스크립스 리서치 인스티튜트 | 변형된 치료제 및 이의 조성물 |
| EP4212180A1 (en) | 2013-12-18 | 2023-07-19 | The Scripps Research Institute | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof |
| US10774114B2 (en) | 2014-03-10 | 2020-09-15 | Fondation The Ark | Respiratory syncytial virus (RSV) replication inhibitors |
| JP6759109B2 (ja) | 2014-05-21 | 2020-09-23 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Ｒａｓ抑制性ペプチドおよびその使用 |
| CA2961029A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
| SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| WO2016149613A2 (en) | 2015-03-18 | 2016-09-22 | Massachusetts Institute Of Technology | Selective mcl-1 binding peptides |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| EP3317294B1 (en) | 2015-07-02 | 2023-03-15 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides |
| CA2995479A1 (en) | 2015-08-28 | 2017-03-09 | Dana-Farber Cancer Institute, Inc. | Peptides binding to bfl-1 |
| KR20180043835A (ko) * | 2015-09-03 | 2018-04-30 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 매크로사이클 및 이의 용도 |
| CN108368161A (zh) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | 作为mcl-1调节剂的拟肽大环化合物 |
| JP7105696B2 (ja) | 2016-02-29 | 2022-07-25 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド |
| AU2017290832B2 (en) | 2016-07-01 | 2023-10-19 | Dana-Farber Cancer Institute, Inc. | Compositions, assays, and methods for direct modulation of fatty acid metabolism |
| WO2018017922A2 (en) | 2016-07-22 | 2018-01-25 | Massachusetts Institute Of Technology | Selective bfl-1 peptides |
| JP7069126B2 (ja) | 2016-08-26 | 2022-05-17 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 化学療法誘発性末梢性ニューロパシーおよび難聴を処置または予防するためのｂｃｌ－ｗポリペプチドおよび模倣物 |
| US12344643B2 (en) | 2016-12-07 | 2025-07-01 | The University Of Chicago | Compositions and methods for inhibition of FOXP3 |
| MA47163A (fr) | 2016-12-16 | 2019-11-06 | Biogen Ma Inc | Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé |
| CA3067047A1 (en) | 2017-07-19 | 2019-01-24 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections |
| EP3737404A1 (en) | 2017-12-15 | 2020-11-18 | Dana Farber Cancer Institute, Inc. | Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive noxa peptides |
| WO2019118893A1 (en) | 2017-12-15 | 2019-06-20 | Dana-Farber Cancer Institute, Inc. | Stabilized peptide-mediated targeted protein degradation |
| US11952432B2 (en) | 2018-02-07 | 2024-04-09 | Dana-Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| EP3765852A1 (en) | 2018-03-14 | 2021-01-20 | Dana Farber Cancer Institute, Inc. | Stabilized peptides for biomarker detection |
| US11091522B2 (en) | 2018-07-23 | 2021-08-17 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| EP3852783A1 (en) | 2018-09-17 | 2021-07-28 | Massachusetts Institute of Technology | Peptides selective for bcl-2 family proteins |
| WO2020215005A1 (en) | 2019-04-18 | 2020-10-22 | Dana-Farber Cancer Institute, Inc. | Selective targeting of ubiquitin- and ubiquitin-like e1-activating enzymes by structurally-stabilized peptides |
| AU2020404876A1 (en) | 2019-12-16 | 2022-07-21 | Dana-Farber Cancer Institute, Inc. | Structurally-stabilized oncolytic peptides and uses thereof |
| CA3162922A1 (en) | 2019-12-20 | 2021-06-24 | Dana-Farber Cancer Institute, Inc. | Structurally-stabilized glucagon-like peptide 1 peptides and uses thereof |
| CA3173973A1 (en) | 2020-03-04 | 2021-09-10 | Dana-Farber Cancer Institute, Inc. | Antiviral structurally-stabilized sars-cov-2 peptides and uses thereof |
| AU2021258205A1 (en) | 2020-04-22 | 2022-10-13 | Dana-Farber Cancer Institute, Inc. | Antiviral structurally-stabilized ACE2 helix 1 peptides and uses thereof |
| CA3179873A1 (en) | 2020-04-27 | 2021-11-04 | Dana-Farber Cancer Institute, Inc. | Structurally-stabilized and hdmx-selective p53 peptides and uses thereof |
| US20230235301A1 (en) * | 2020-06-04 | 2023-07-27 | The Trustees Of The University Of Pennsylvania | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis |
| CA3193261A1 (en) | 2020-10-14 | 2022-04-21 | Dana-Farber Cancer Institute, Inc. | Chimeric conjugates for degradation of viral and host proteins and methods of use |
| US20240002450A1 (en) | 2020-11-05 | 2024-01-04 | Dana-Farber Cancer Institute, Inc. | Antiviral structurally-stabilized ebolavirus peptides and uses thereof |
| KR20240032010A (ko) | 2021-06-09 | 2024-03-08 | 더 스크립스 리서치 인스티튜트 | 장기 지속형 이중 gip/glp-1 펩타이드 접합체 및 사용 방법 |
| EP4122944A1 (en) | 2021-07-21 | 2023-01-25 | EnzyTag B.V. | Enzymatic synthesis of cyclic peptides |
| JP2024533273A (ja) | 2021-09-08 | 2024-09-12 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 抗ウイルス性の構造的にステープル化されたＳＡＲＳ－ＣｏＶ－２ペプチド－コレステロールコンジュゲートおよびその使用 |
| WO2023215784A1 (en) | 2022-05-04 | 2023-11-09 | Dana-Farber Cancer Institute, Inc. | Ebolavirus surface glycoprotein peptides, conjugates, and uses thereof |
| WO2026024936A2 (en) | 2024-07-25 | 2026-01-29 | Dana-Farber Cancer Institute, Inc. | Bh4 domain peptides and uses thereof |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811515A (en) | 1995-06-12 | 1998-09-22 | California Institute Of Technology | Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis |
| CA2363077A1 (en) | 1999-03-01 | 2000-09-08 | Variagenics, Inc. | Methods for targeting rna molecules |
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| DK2604285T3 (en) | 2003-05-01 | 2014-12-01 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| CA2544223C (en) * | 2003-11-05 | 2017-03-07 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| GB2427550B (en) * | 2004-03-17 | 2007-05-30 | 7Tm Pharma As | Y2/Y4 selective receptor agonists for therapeutic interventions |
| EP1737884B1 (en) * | 2004-03-19 | 2016-10-19 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| WO2005118620A2 (en) | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| BRPI0511755A (pt) * | 2004-06-01 | 2008-01-02 | Domantis Ltd | composições, fusões e conjugados de drogas e métodos de produção, tratamento e utilização |
| US7084248B2 (en) | 2004-07-14 | 2006-08-01 | Gene Tools, Llc | Peptide composition and method for delivering substances into the cytosol of cells |
| BRPI0518761A2 (pt) * | 2004-12-02 | 2008-12-09 | Domantis Ltd | fusço de droga, conjugado de droga, Ácido nucleico recombinante, construÇço de Ácido nucleico, cÉlula hospedeira, mÉtodo para produzir uma fusço de droga, composiÇço farmacÊutica, droga, mÉtodo de tratamento e/ou prevenÇço de uma condiÇço em um paciente, mÉtodo de retardo ou prevenÇço de progressço de doenÇa, e, mÉtodo para diminuir a absorÇço de alimentos por um paciente |
| WO2006103666A2 (en) | 2005-03-28 | 2006-10-05 | Yeda Research And Development Co. Ltd. | Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| CA2669696A1 (en) | 2006-11-15 | 2008-05-22 | Dana-Farber Cancer Institute, Inc. | Stabilized maml peptides and uses thereof |
| US7981998B2 (en) | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| EP3170835A1 (en) | 2006-12-14 | 2017-05-24 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
| WO2008095063A1 (en) | 2007-01-31 | 2008-08-07 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2564863B1 (en) | 2007-02-23 | 2017-08-23 | Aileron Therapeutics, Inc. | Triazole linked macrocyclic peptides |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| ES2637687T3 (es) | 2007-05-02 | 2017-10-16 | Dana-Farber Cancer Institute, Inc. | Péptido BAD de dominio BH3 para usar en el tratamiento o retardo de la aparición de la diabetes |
| US8871899B2 (en) | 2007-12-31 | 2014-10-28 | New York University | Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| WO2009108261A2 (en) | 2008-01-23 | 2009-09-03 | Dana Farber Cancer Institute | Compositions and methods for the treatment of viral infections |
| US20090275519A1 (en) | 2008-02-08 | 2009-11-05 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
| US20110144303A1 (en) | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
| WO2009126292A2 (en) | 2008-04-08 | 2009-10-15 | Aileron Therapeutics, Inc. | Biologically active peptidomimetic macrocycles |
| WO2009149214A2 (en) | 2008-06-03 | 2009-12-10 | Aileron Therapeutics, Inc. | Compositions and methods for enhancing cellular transport of biomolecules |
| EP2356139A4 (en) | 2008-07-23 | 2013-01-09 | Harvard College | LIGURE COMBINED POLYPEPTIDES |
| BRPI0919414A2 (pt) | 2008-09-18 | 2017-07-11 | Univ New York | Inibição da interação entre hif-1alfa e p300/cbp com hélices à base de substituintes de ligação de hidrogênio |
| CA2737918A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| US20120115783A1 (en) | 2008-09-22 | 2012-05-10 | Alleron therapeutics, Inc | Peptidomimetic macrocycles |
| WO2010034034A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| EP2334697A1 (en) | 2008-09-22 | 2011-06-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| US20120101047A1 (en) | 2008-09-22 | 2012-04-26 | Aileron Therapetics Inc. | Peptidomimetic macrocycles |
| AU2009294875C1 (en) | 2008-09-22 | 2015-05-14 | Aileron Therapeutics, Inc. | Methods for preparing purified polypeptide compositions |
| WO2010060112A1 (en) | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
| BRPI1006139A2 (pt) | 2009-01-14 | 2017-05-30 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
| AU2010273220B2 (en) | 2009-07-13 | 2015-10-15 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| EP2480565A4 (en) | 2009-09-22 | 2014-01-01 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES |
| US20110223149A1 (en) | 2009-10-14 | 2011-09-15 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN103282510A (zh) | 2010-08-13 | 2013-09-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| JP6239979B2 (ja) | 2011-03-04 | 2017-11-29 | ニューヨーク・ユニバーシティ | Ｒａｓの調節因子としての水素結合代替大環状分子 |
| WO2012173846A2 (en) | 2011-06-06 | 2012-12-20 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN103889437A (zh) | 2011-08-31 | 2014-06-25 | 纽约大学 | 硫醚、醚和烷基胺连接的氢键替代物肽模拟物 |
| KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| WO2013059530A2 (en) | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス，インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
| WO2013123266A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| US9068805B2 (en) | 2013-06-26 | 2015-06-30 | Matthew James Owen | Arrow modification and fletching system |
| US20170037086A1 (en) | 2014-04-09 | 2017-02-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with pth activity |
-
2009
- 2009-11-24 WO PCT/US2009/065824 patent/WO2010060112A1/en not_active Ceased
- 2009-11-24 BR BRPI0920899A patent/BRPI0920899A2/pt not_active Application Discontinuation
- 2009-11-24 CN CN2009801468497A patent/CN102223891A/zh active Pending
- 2009-11-24 US US12/625,533 patent/US9458202B2/en not_active Expired - Fee Related
- 2009-11-24 EP EP09828398A patent/EP2352507A4/en not_active Withdrawn
- 2009-11-24 AU AU2009316288A patent/AU2009316288B2/en not_active Ceased
- 2009-11-24 CA CA2743177A patent/CA2743177A1/en not_active Abandoned
- 2009-11-24 JP JP2011537728A patent/JP2012509902A/ja active Pending
-
2011
- 2011-05-05 IL IL212748A patent/IL212748A/en active IP Right Grant
-
2015
- 2015-01-26 JP JP2015012176A patent/JP6194325B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-10 US US15/233,796 patent/US20170212125A1/en not_active Abandoned
- 2016-08-19 AU AU2016216698A patent/AU2016216698B2/en not_active Ceased
-
2017
- 2017-06-16 JP JP2017118484A patent/JP2017186363A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012509902A5 (Direct) | ||
| JP2015091868A5 (Direct) | ||
| ES2548515T3 (es) | Complejos lipídicos recubiertos con PEG y su uso | |
| JP2020502051A5 (Direct) | ||
| JP6223377B2 (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| CA2476589C (en) | Compositions for delivery of therapeutics and other materials, and methods of making and using the same | |
| JP2018123169A (ja) | ヘプシジン類似体及びその使用 | |
| CN102037058B (zh) | 多西紫杉醇高分子衍生物、及其制造方法及其用途 | |
| CN102762586B (zh) | 治疗肽 | |
| JP2017528444A5 (Direct) | ||
| JP2012255007A5 (Direct) | ||
| JP2014526881A5 (Direct) | ||
| JP2017523959A (ja) | ヘプシジンおよびミニ−ヘプシジンアナログおよびその使用 | |
| RU2012106150A (ru) | Вариантные формы уратоксидазы и их применение | |
| JP2012126750A5 (Direct) | ||
| JP2011530599A5 (Direct) | ||
| JP2006502741A5 (Direct) | ||
| JP2017531613A5 (Direct) | ||
| JP2009537624A5 (Direct) | ||
| JP2017523781A5 (Direct) | ||
| JP6633523B2 (ja) | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 | |
| JP2025063139A (ja) | リンカー | |
| TW201811817A (zh) | 血小板反應素１結合肽 | |
| EP3601314A1 (en) | Npra agonists, compositions, and uses thereof | |
| JP2022502347A (ja) | 細胞透過性ペプチド |